Company Moves: The Latest in the Global Generics Market - DCAT Value Chain Insights

Novartis’ decision to spin out Sandoz, its generics and biosimilars business, into a separate, stand-alone company is the latest move in the highly cost-competitive generics market. What was behind Novartis’ decision, and how does it fit with other recent deals?

Specialty Injectable Generics Market Research 2024 Industry Demand and Scope

Applied Sciences, Free Full-Text

Exploring opportunities in the gen AI value chain

Is Open Collaboration The New Paradigm In Pharmaceutical Manufacturing Innovation

Construction Machinery Market Share, Trends And Growth Analysis Report 2033

Week in Review: Adapting to Tomorrow—Bridging Pharma Gaps, Changing Consumer Habits & Reinforcing Food Logistics

Construction Equipment Market Size & Share Report, 2030

Veterinary Equipment and Disposables Market Size, Share-2031

The 7 Data Habits of World-Class Product Companies

Pursuing the End-of-Life Tire Circularity: An Outlook toward the Production of Secondary Raw Materials from Tire Pyrolysis Oil

Osmometer Market 2023 (New Data Insights): Comprehensive Analysis, Industry Outlook, and Forecast for 2029